This is to inform that the company has received trading approval from the stock exchange for 1,55,10,000 equity shares of the company pursuant to the conversion of 1,55,10,000 warrants ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Integrated Proteins Ltd has received trading approval from BSE for 1,55,10,000 (approximately 1.55 crore) equity shares of face value Rs. 10 each, issued at a premium of Rs. 1.25 per share (total issue price Rs. 11.25). These shares were allotted on a preferential basis to non-promoters following the conversion of warrants held by them. The new shares carry distinctive numbers from 3675201 to 19185200 and will be available for trading from December 18, 2025. This increases the listed equity share base of the company. The total fresh capital raised through this allotment works out to approximately Rs. 1.74 crore at the stated issue price.
Shareholders should note a dilution of equity as over 1.55 crore new shares enter the traded float, which could weigh on the stock price in the short term due to increased supply. However, the additional capital strengthens the company's equity base marginally.